Lang B, LoGalbo P R, Sanchez B, Winchester R
Department of Rheumatic Diseases, Hospital for Joint Diseases, New York, NY 10003.
Hum Immunol. 1988 Sep;23(1):59-70. doi: 10.1016/0198-8859(88)90018-3.
In the process of studying the fine specificity of HLA class II molecules, we identified an alloreactive T-cell clone raised to a HLA-Dw14 homozygous cell line that was specifically stimulated by Dw14+ homozygous typing cells but negatively with cells expressing the HLA-Dw4,-Dw10, -Dw13, and -Dw15 subspecificities of DR4. Of interest, this clone was also equivalently activated by stimulation with all DR3 cells and cell lines tested. Negative responses were obtained using a panel of 87 non-DR3 and non-Dw14 cells, including cell lines of the Tenth Histocompatibility Workshop. A monoclonal antibody inhibition study revealed the relevant stimulating determinant to be on HLA-DR molecules in both Dw14- and DR3-positive cells. A comparison of the DR beta 1-chain-inferred amino acid sequences suggests that formation of a topologically equivalent stimulating determinant would involve the participation of two noncontiguous regions of the third diversity region of DR beta 1. The putative recognition conformation detected by the clone is most probably specified by the presence of a valine at position 86 and a nonnegatively charged residue at positions 70, 71, and 74, since these are the only residues where DR3 and Dw14 are distinguishable from all other HLA-DR types. These findings illustrate that the functional ability of class II molecules is not necessarily either illustrated or predicted by serologic typing or by simple considerations of amino acid sequence.
在研究HLA II类分子精细特异性的过程中,我们鉴定出一个针对HLA - Dw14纯合细胞系产生的同种异体反应性T细胞克隆,该克隆被Dw14 +纯合分型细胞特异性刺激,但对表达DR4的HLA - Dw4、- Dw10、- Dw13和- Dw15亚特异性的细胞呈阴性反应。有趣的是,用所有测试的DR3细胞和细胞系刺激该克隆时,也能使其等效激活。使用一组87个非DR3和非Dw14细胞(包括第十届组织相容性研讨会的细胞系)获得了阴性反应。单克隆抗体抑制研究表明,Dw14阴性和DR3阳性细胞中的相关刺激决定簇都位于HLA - DR分子上。对DRβ1链推导的氨基酸序列进行比较表明,形成拓扑等效的刺激决定簇将涉及DRβ1第三可变区两个不相邻区域的参与。该克隆检测到的推定识别构象很可能由86位的缬氨酸以及70、71和74位的非负电荷残基决定,因为这些是DR3和Dw14与所有其他HLA - DR类型唯一可区分的残基。这些发现表明,II类分子的功能能力不一定能通过血清学分型或简单的氨基酸序列考虑来阐明或预测。